IE32961L - 2-alkoxy-3, 5-dihalobenzene alkylaminoalkyl ethers - Google Patents

2-alkoxy-3, 5-dihalobenzene alkylaminoalkyl ethers

Info

Publication number
IE32961L
IE32961L IE690173A IE17369A IE32961L IE 32961 L IE32961 L IE 32961L IE 690173 A IE690173 A IE 690173A IE 17369 A IE17369 A IE 17369A IE 32961 L IE32961 L IE 32961L
Authority
IE
Ireland
Prior art keywords
alkyl
alkoxy
acid
acetylating
monoether
Prior art date
Application number
IE690173A
Other versions
IE32961B1 (en
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR151632A external-priority patent/FR7615M/fr
Application filed by Ile De France filed Critical Ile De France
Publication of IE32961L publication Critical patent/IE32961L/en
Publication of IE32961B1 publication Critical patent/IE32961B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Insulating Bodies (AREA)

Abstract

1,251,695. Aminoalkyl ethers of 2-(alkoxy) - 3,5-dihalobenzenes. SOC. D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE. 13 Feb., 1969 [16 Feb., 1968; 10 May, 1968], No. 7933/69. HeadingC2C. Novel compounds of the Formula (I) and their acid-addition salts with a mineral or organic acid and their quaternary ammonium salts, wherein n and m each is 0, 1 or 2, R, R l and R 2 each is H or C 1-5 alkyl, R 3 is C 1-5 alkyl, or the group NR 1 R 2 represents a heterocyclic radical, and X and Y are halogens, are obtained by acetylating a monoether of pyrocatechol, then halogenating the product, de-acetylating the halogenated product and treating the dihalo-pyrocatechol monoether with an appropriate (substituted amino) alkyl chloride, and optionally forming acid or quaternary ammonium salts. Pharmaceutical compositions, useful as spasmogenie agents, contain compounds of Formula (I) above as active ingredients, and may be formulated as tablets or solutions. [GB1251695A]
IE173/69A 1968-02-16 1969-02-11 New dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and process for the preparation thereof IE32961B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR140294 1968-02-16
FR151632A FR7615M (en) 1968-05-10 1968-05-10

Publications (2)

Publication Number Publication Date
IE32961L true IE32961L (en) 1969-08-16
IE32961B1 IE32961B1 (en) 1974-02-06

Family

ID=26181810

Family Applications (1)

Application Number Title Priority Date Filing Date
IE173/69A IE32961B1 (en) 1968-02-16 1969-02-11 New dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and process for the preparation thereof

Country Status (21)

Country Link
JP (1) JPS4934669B1 (en)
BE (1) BE728221A (en)
BG (1) BG15205A3 (en)
BR (1) BR6906462D0 (en)
CA (1) CA928299A (en)
CH (1) CH490328A (en)
CS (1) CS155198B2 (en)
DK (1) DK125020B (en)
ES (1) ES363662A1 (en)
FI (1) FI50789C (en)
GB (1) GB1251695A (en)
IE (1) IE32961B1 (en)
IL (1) IL31594A (en)
LU (1) LU58009A1 (en)
MC (1) MC809A1 (en)
NL (1) NL138921B (en)
NO (1) NO128958B (en)
OA (1) OA03885A (en)
SE (1) SE367184B (en)
YU (1) YU33793B (en)
ZM (1) ZM969A1 (en)

Also Published As

Publication number Publication date
IL31594A0 (en) 1969-04-30
IL31594A (en) 1973-02-28
FI50789C (en) 1976-07-12
NL6902401A (en) 1969-08-19
ES363662A1 (en) 1971-01-01
DK125020B (en) 1972-12-18
BG15205A3 (en) 1972-05-20
BE728221A (en) 1969-08-11
DE1906551B2 (en) 1975-07-17
CH490328A (en) 1970-05-15
NL138921B (en) 1973-05-15
OA03885A (en) 1975-08-14
CS155198B2 (en) 1974-05-30
NO128958B (en) 1974-02-04
LU58009A1 (en) 1969-09-18
CA928299A (en) 1973-06-12
BR6906462D0 (en) 1973-01-16
JPS4934669B1 (en) 1974-09-17
ZM969A1 (en) 1969-11-17
MC809A1 (en) 1970-07-30
SE367184B (en) 1974-05-20
YU33793B (en) 1978-05-15
DE1906551A1 (en) 1969-08-21
IE32961B1 (en) 1974-02-06
YU33269A (en) 1977-10-31
FI50789B (en) 1976-03-31
GB1251695A (en) 1971-10-27

Similar Documents

Publication Publication Date Title
HK48685A (en) Cyclosporin derivatives, their production and pharmaceutical compositions containing them
IE791565L (en) Crop cutting apparatus
IE33269B1 (en) Pyridobenzo-diazepine derivatives
JPS5520800A (en) Cephem compounds, their salts, their preparation, and preventive or remedy for microbism containing the same as the effective component
JPS5777689A (en) Novel cephen compound, or its salt, its preparation, and preventive it as active ingredient
DE3060897D1 (en) Sisomicin derivatives, process for their preparation and their use as medicines
GB1251695A (en)
ATE3769T1 (en) 1-IMIDAZOLE-2-YLIDENE-3-THIENYL UREA DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
JPS5626814A (en) Antibacteria agent and its use
CA2128202A1 (en) Alkyl Derivatives of Trazodone with CNS Activity
MY8600065A (en) 2-substituted-4-alkyl or trihaloalkyl-5-oxazoleoarboxylic acid derivatives, their use as safening agents and herbicides composition containing them
JPS54128588A (en) Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
ES8607973A1 (en) Amino-lower-alkyl-penem derivatives, process for their preparation, pharmaceutical compositions containing them and their use.
ZA796386B (en) New process for preparing derivatives of piperidyl-indole,new compound obtained and its salts,their use as medicaments and the pharmaceutical compositions containing them
DE2962464D1 (en) 2-(1-phenyl-2,5-cyclohexadienyl)-ethylamine derivatives, process for their preparation, their use as active pharmaceutical agents and pharmaceutical compositions containing them
JPS56103185A (en) Malonamidoxa-dethia-cephem compound
JPS5616489A (en) Imidazolecarboxylic acid derivative
JPS56142282A (en) Penem-3-carboxylic acid derivative and its preparation
GB1490476A (en) 6-aminomethylated-3-oxygenated cholest-5-enes
JPS56142283A (en) Penem-3-carboxylic acid derivative and its preparation
FR2453850A1 (en) NOVEL 16-METHOXY-16-METHYL-PROSTAGLANDIN E1 DERIVATIVES USEFUL IN PARTICULAR AS GASTROPROTECTIVE AGENTS AND THEIR PREPARATION PROCESS
JPS5646883A (en) Novel cephalosporin compound and its preparation
JPS5540631A (en) Novel beta-lactam compound and its preparation
GB1370871A (en) Quaternary imidazole derivatives and their use as surface active compounds
ES8103774A1 (en) A PROCEDURE FOR PREPARING NEW TRIAZENE COMPOUNDS